|Assembly Biosciences Inc -- USA Stock|| |
USD 56.82 1.06 1.83%
Mr. David J. Barrett CPA, is Chief Financial Officer, Chief Operating Officer of Company. From April 2006 to September 2009, Mr. Barrett served as Chief Financial Officer of NeuroHitech, Inc., a public company focused on developing, marketing and distributing branded and generic pharmaceutical products. From September 2003 to April 2006, Mr. Barrett was the Chief Financial OfficerVice President of Finance of Overture Asset Managers and Overture Financial Services, which, at the time, was a startup asset management firm that assembled investment products and platforms to distribute turnkey and unbundled investment solutions to financial intermediaries and institutional investors. From July 1999 to September 2003, Mr. Barrett was employed as a Manager at Deloitte Touche, LLP. Mr. Barrett also is a director of Coronado Biosciences, Inc., a biopharmaceutical Company
Age: 38 COO Since 2015
Barrett received his B.S. in Accounting and Economics and his M.S. in Accounting from the University of Florida. He is a certified public accountant.
David Barrett Latest Insider Activity
The company has return on total asset (ROA)
of (29.25) %
which means that it has lost $29.25 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (74.86) %
meaning that it created substantial loss on money invested by shareholders.
Assembly Biosciences, Inc., a clinical stage biotechnology company, develops oral therapeutics for the treatment of hepatitis B virus infection and novel class of oral synthetic live biotherapeutics to restore health to a dysbiotic microbiome in the United States. Assembly Biosciences, Inc. was founded in 2005 and is headquartered in Carmel, Indiana. Assembly Biosciences operates under Drug Manufacturers - Major classification in USA and traded on Nasdaq Capital Markets exchange. It employs 80 people.Assembly Biosciences Inc (ASMB) is traded on Nasdaq Capital Markets in USA. It is located in NEW YORK, U.S.A and employs 80 people. Assembly Biosciences is listed under Pharmaceutical Products category by Fama And French industry classification.